Evidence map›Paper›PMID 39399550›Full record

ArticleNeurology. Clinical practice2025

Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.

Adalia Jun-O'Connell, Brian Silver, Eliza Grigoriciuc, Akanksha Gulati, Kimiyoshi J Kobayashi, Nils Henninger

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adalia Jun-O'ConnellDepartments of Neurology (AJ-OC, BS, EG, AG, NH); Internal Medicine (KJK), and Psychiatry (NH), University of Massachusetts Chan Medical School, Worcester.ORCID https://orcid.org/0000-0003-0667-2951
Brian SilverDepartments of Neurology (AJ-OC, BS, EG, AG, NH); Internal Medicine (KJK), and Psychiatry (NH), University of Massachusetts Chan Medical School, Worcester.ORCID https://orcid.org/0000-0002-1562-9894
Eliza GrigoriciucDepartments of Neurology (AJ-OC, BS, EG, AG, NH); Internal Medicine (KJK), and Psychiatry (NH), University of Massachusetts Chan Medical School, Worcester.ORCID https://orcid.org/0009-0000-2516-8115
Akanksha GulatiDepartments of Neurology (AJ-OC, BS, EG, AG, NH); Internal Medicine (KJK), and Psychiatry (NH), University of Massachusetts Chan Medical School, Worcester.ORCID https://orcid.org/0000-0001-8672-1746
Kimiyoshi J KobayashiDepartments of Neurology (AJ-OC, BS, EG, AG, NH); Internal Medicine (KJK), and Psychiatry (NH), University of Massachusetts Chan Medical School, Worcester.ORCID https://orcid.org/0009-0003-1796-7023
Nils HenningerDepartments of Neurology (AJ-OC, BS, EG, AG, NH); Internal Medicine (KJK), and Psychiatry (NH), University of Massachusetts Chan Medical School, Worcester.ORCID https://orcid.org/0000-0002-3883-5623

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: A higher LACE+ index risk category (defined as LACE+ score ≥78) typically calculated before hospital discharge has been associated with increased risk of unplanned 30-day hospital readmissions and early death after hospital discharge. However, its utility to predict poststroke mortality is unknown. Here, we examined whether the LACE+ index risk category assessed at both discharge (dLACE+) and admission (aLACE+) was associated with 90-day mortality after stroke. Methods: We retrospectively analyzed 2,729 consecutive patients who presented with ischemic or hemorrhagic strokes, included in an institutional stroke registry between January 2018 and December 2021. The primary outcome of interest was 90-day mortality after the index hospitalization. Patients were categorized as high-risk (≥78), medium-to-high-risk (59-77), and low-to-medium-risk (0-58) according to the LACE+ as automatically calculated at admission and discharge. Analyses were performed on the entire cohort, as well as stratified according to acute ischemic stroke and hemorrhagic stroke diagnosis. Results: Among patients who completed 90-day follow-up, the mortality rate was 24.3% (576/2368). In the Kaplan-Meier analysis, the high-risk aLACE+ group had the highest 90-day mortality rate as compared with low-to-medium-risk and medium-to-high-risk groups ( Discussion: The LACE+ calculated at both admission and discharge admission identified patients with stroke at increased risk for 90-day mortality. Future studies are warranted to determine whether LACE+ score-based risk stratification can be used to devise early interventions to mitigate the risk for death.

Identifiers

PMID39399550
PMCPMC11464223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.